TW202408468A - 眼科組成物 - Google Patents
眼科組成物 Download PDFInfo
- Publication number
- TW202408468A TW202408468A TW112125156A TW112125156A TW202408468A TW 202408468 A TW202408468 A TW 202408468A TW 112125156 A TW112125156 A TW 112125156A TW 112125156 A TW112125156 A TW 112125156A TW 202408468 A TW202408468 A TW 202408468A
- Authority
- TW
- Taiwan
- Prior art keywords
- ophthalmic composition
- container
- tramadol
- salts
- buffer
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Ophthalmology & Optometry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022109259 | 2022-07-06 | ||
| JP2022-109259 | 2022-07-06 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TW202408468A true TW202408468A (zh) | 2024-03-01 |
Family
ID=89453510
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW112125156A TW202408468A (zh) | 2022-07-06 | 2023-07-05 | 眼科組成物 |
Country Status (3)
| Country | Link |
|---|---|
| JP (1) | JPWO2024010044A1 (https=) |
| TW (1) | TW202408468A (https=) |
| WO (1) | WO2024010044A1 (https=) |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI0710085B8 (pt) * | 2006-03-31 | 2021-05-25 | Vistakon Pharmaceutical Llc | composições oftálmicas e seus kits |
| MX346312B (es) * | 2011-04-05 | 2017-03-15 | Optosolve Res & Dev Ltd | Tratamientos oftalmicos. |
| ES2604816B1 (es) * | 2015-09-09 | 2018-01-29 | Farmalider, S.A. | Composición farmacéutica de tramadol para uso oftálmico |
| JPWO2019026992A1 (ja) * | 2017-08-03 | 2020-06-18 | 参天製薬株式会社 | クロルヘキシジンを含有する医薬組成物 |
| JP6855632B1 (ja) * | 2020-02-19 | 2021-04-07 | 千寿製薬株式会社 | 医薬製品 |
| WO2021222368A1 (en) * | 2020-04-30 | 2021-11-04 | Irenix Medical, Inc. | Sodium chlorite compositions with enhanced anti-viral and anti-microbial efficacy and reduced toxicity |
| JP2022044701A (ja) * | 2022-01-24 | 2022-03-17 | 参天製薬株式会社 | インジェクションブロー成形されたマルチドーズ型点眼容器に収容される水性懸濁液 |
-
2023
- 2023-07-05 JP JP2024532618A patent/JPWO2024010044A1/ja active Pending
- 2023-07-05 TW TW112125156A patent/TW202408468A/zh unknown
- 2023-07-05 WO PCT/JP2023/024978 patent/WO2024010044A1/ja not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2024010044A1 (ja) | 2024-01-11 |
| JPWO2024010044A1 (https=) | 2024-01-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2901140T3 (es) | Composiciones farmacéuticas de atropina | |
| TWI874894B (zh) | 含阿托平之水性組成物 | |
| US20230190639A1 (en) | Formulations of vasopressin | |
| TW202408468A (zh) | 眼科組成物 | |
| JP7245383B1 (ja) | ジクアホソルまたはその塩を含有する眼科用組成物のpHの低下を抑制する方法 | |
| US20240216323A1 (en) | Topical formulations of chloroprocaine and methods of using same | |
| TW202408472A (zh) | 眼科組成物 | |
| TW202408467A (zh) | 眼科組成物 | |
| EP1926472B1 (en) | Stabilized and preserved ketotifen ophthalmic compositions | |
| AU2010235948B2 (en) | Stabilized and preserved ketotifen ophthalmic compositions | |
| JP4607761B2 (ja) | 溶液医薬組成物 | |
| HK40115731A (zh) | 眼科组合物 | |
| WO2025146828A1 (ja) | 眼科組成物 | |
| JP2004269363A (ja) | アセトアミノフェンを含有する安定な水性医薬組成物 | |
| EP4534082A1 (en) | Ophthalmic composition | |
| WO2024203727A1 (ja) | 水性組成物 | |
| WO2025079591A1 (ja) | セペタプロストを含有する点眼液 | |
| HK40115979A (zh) | 眼科组合物 | |
| WO2024135344A1 (ja) | 眼科用製品 | |
| JP2024090829A (ja) | 滅菌容器に収容されるエピナスチン含有水性医薬組成物 | |
| JP2026062549A (ja) | 眼科用組成物 | |
| BR112019023515B1 (pt) | Composição oftálmica de atropina líquida de baixa dosagem, estável em armazenamento, método para aumentar a estabilidade de armazenamento de atropina em dita composição, kit de tratamento para tratamento de miopia e uso de dita composição |